This report aims to provide a comprehensive presentation of the global market for Peptide-Drug Conjugates, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peptide-Drug Conjugates. This report contains market size and forecasts of Peptide-Drug Conjugates in global, including the following market information:
Global Peptide-Drug Conjugates Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global Peptide-Drug Conjugates market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Cell-penetrating Peptides (CPPs) Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Peptide-Drug Conjugates include AstraZeneca, Bicycle Therapeutics, Cybrexa Therapeutics, Esperance Pharmaceuticals, Oncopeptides, Pepgen Corporation, Soricimed Biopharma and Theratechnologies, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
WE surveyed the Peptide-Drug Conjugates companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Peptide-Drug Conjugates Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Peptide-Drug Conjugates Market Segment Percentages, by Type, 2022 (%)
Cell-penetrating Peptides (CPPs)
Cell-targeting Peptides (CTPs)
Global Peptide-Drug Conjugates Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Peptide-Drug Conjugates Market Segment Percentages, by Application, 2022 (%)
Carcinoma
Sarcoma
Melanoma
Lymphoma
Leukemia
Global Peptide-Drug Conjugates Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Peptide-Drug Conjugates Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Peptide-Drug Conjugates revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Peptide-Drug Conjugates revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca
Bicycle Therapeutics
Cybrexa Therapeutics
Esperance Pharmaceuticals
Oncopeptides
Pepgen Corporation
Soricimed Biopharma
Theratechnologies
Outline of Major Chapters:
Chapter 1: Introduces the definition of Peptide-Drug Conjugates, market overview.
Chapter 2: Global Peptide-Drug Conjugates market size in revenue.
Chapter 3: Detailed analysis of Peptide-Drug Conjugates company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Peptide-Drug Conjugates in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Peptide-Drug Conjugates Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Peptide-Drug Conjugates Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Peptide-Drug Conjugates Overall Market Size
2.1 Global Peptide-Drug Conjugates Market Size: 2022 VS 2032
2.2 Global Peptide-Drug Conjugates Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Peptide-Drug Conjugates Players in Global Market
3.2 Top Global Peptide-Drug Conjugates Companies Ranked by Revenue
3.3 Global Peptide-Drug Conjugates Revenue by Companies
3.4 Top 3 and Top 5 Peptide-Drug Conjugates Companies in Global Market, by Revenue in 2022
3.5 Global Companies Peptide-Drug Conjugates Product Type
3.6 Tier 1, Tier 2 and Tier 3 Peptide-Drug Conjugates Players in Global Market
3.6.1 List of Global Tier 1 Peptide-Drug Conjugates Companies
3.6.2 List of Global Tier 2 and Tier 3 Peptide-Drug Conjugates Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Peptide-Drug Conjugates Market Size Markets, 2022 & 2032
4.1.2 Cell-penetrating Peptides (CPPs)
4.1.3 Cell-targeting Peptides (CTPs)
4.2 By Type - Global Peptide-Drug Conjugates Revenue & Forecasts
4.2.1 By Type - Global Peptide-Drug Conjugates Revenue, 2018-2023
4.2.2 By Type - Global Peptide-Drug Conjugates Revenue, 2024-2032
4.2.3 By Type - Global Peptide-Drug Conjugates Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Peptide-Drug Conjugates Market Size, 2022 & 2032
5.1.2 Carcinoma
5.1.3 Sarcoma
5.1.4 Melanoma
5.1.5 Lymphoma
5.1.6 Leukemia
5.2 By Application - Global Peptide-Drug Conjugates Revenue & Forecasts
5.2.1 By Application - Global Peptide-Drug Conjugates Revenue, 2018-2023
5.2.2 By Application - Global Peptide-Drug Conjugates Revenue, 2024-2032
5.2.3 By Application - Global Peptide-Drug Conjugates Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Peptide-Drug Conjugates Market Size, 2022 & 2032
6.2 By Region - Global Peptide-Drug Conjugates Revenue & Forecasts
6.2.1 By Region - Global Peptide-Drug Conjugates Revenue, 2018-2023
6.2.2 By Region - Global Peptide-Drug Conjugates Revenue, 2024-2032
6.2.3 By Region - Global Peptide-Drug Conjugates Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Peptide-Drug Conjugates Revenue, 2018-2032
6.3.2 US Peptide-Drug Conjugates Market Size, 2018-2032
6.3.3 Canada Peptide-Drug Conjugates Market Size, 2018-2032
6.3.4 Mexico Peptide-Drug Conjugates Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Peptide-Drug Conjugates Revenue, 2018-2032
6.4.2 Germany Peptide-Drug Conjugates Market Size, 2018-2032
6.4.3 France Peptide-Drug Conjugates Market Size, 2018-2032
6.4.4 U.K. Peptide-Drug Conjugates Market Size, 2018-2032
6.4.5 Italy Peptide-Drug Conjugates Market Size, 2018-2032
6.4.6 Russia Peptide-Drug Conjugates Market Size, 2018-2032
6.4.7 Nordic Countries Peptide-Drug Conjugates Market Size, 2018-2032
6.4.8 Benelux Peptide-Drug Conjugates Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Peptide-Drug Conjugates Revenue, 2018-2032
6.5.2 China Peptide-Drug Conjugates Market Size, 2018-2032
6.5.3 Japan Peptide-Drug Conjugates Market Size, 2018-2032
6.5.4 South Korea Peptide-Drug Conjugates Market Size, 2018-2032
6.5.5 Southeast Asia Peptide-Drug Conjugates Market Size, 2018-2032
6.5.6 India Peptide-Drug Conjugates Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Peptide-Drug Conjugates Revenue, 2018-2032
6.6.2 Brazil Peptide-Drug Conjugates Market Size, 2018-2032
6.6.3 Argentina Peptide-Drug Conjugates Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Peptide-Drug Conjugates Revenue, 2018-2032
6.7.2 Turkey Peptide-Drug Conjugates Market Size, 2018-2032
6.7.3 Israel Peptide-Drug Conjugates Market Size, 2018-2032
6.7.4 Saudi Arabia Peptide-Drug Conjugates Market Size, 2018-2032
6.7.5 UAE Peptide-Drug Conjugates Market Size, 2018-2032
7 Peptide-Drug Conjugates Companies Profiles
7.1 AstraZeneca
7.1.1 AstraZeneca Company Summary
7.1.2 AstraZeneca Business Overview
7.1.3 AstraZeneca Peptide-Drug Conjugates Major Product Offerings
7.1.4 AstraZeneca Peptide-Drug Conjugates Revenue in Global Market (2018-2023)
7.1.5 AstraZeneca Key News & Latest Developments
7.2 Bicycle Therapeutics
7.2.1 Bicycle Therapeutics Company Summary
7.2.2 Bicycle Therapeutics Business Overview
7.2.3 Bicycle Therapeutics Peptide-Drug Conjugates Major Product Offerings
7.2.4 Bicycle Therapeutics Peptide-Drug Conjugates Revenue in Global Market (2018-2023)
7.2.5 Bicycle Therapeutics Key News & Latest Developments
7.3 Cybrexa Therapeutics
7.3.1 Cybrexa Therapeutics Company Summary
7.3.2 Cybrexa Therapeutics Business Overview
7.3.3 Cybrexa Therapeutics Peptide-Drug Conjugates Major Product Offerings
7.3.4 Cybrexa Therapeutics Peptide-Drug Conjugates Revenue in Global Market (2018-2023)
7.3.5 Cybrexa Therapeutics Key News & Latest Developments
7.4 Esperance Pharmaceuticals
7.4.1 Esperance Pharmaceuticals Company Summary
7.4.2 Esperance Pharmaceuticals Business Overview
7.4.3 Esperance Pharmaceuticals Peptide-Drug Conjugates Major Product Offerings
7.4.4 Esperance Pharmaceuticals Peptide-Drug Conjugates Revenue in Global Market (2018-2023)
7.4.5 Esperance Pharmaceuticals Key News & Latest Developments
7.5 Oncopeptides
7.5.1 Oncopeptides Company Summary
7.5.2 Oncopeptides Business Overview
7.5.3 Oncopeptides Peptide-Drug Conjugates Major Product Offerings
7.5.4 Oncopeptides Peptide-Drug Conjugates Revenue in Global Market (2018-2023)
7.5.5 Oncopeptides Key News & Latest Developments
7.6 Pepgen Corporation
7.6.1 Pepgen Corporation Company Summary
7.6.2 Pepgen Corporation Business Overview
7.6.3 Pepgen Corporation Peptide-Drug Conjugates Major Product Offerings
7.6.4 Pepgen Corporation Peptide-Drug Conjugates Revenue in Global Market (2018-2023)
7.6.5 Pepgen Corporation Key News & Latest Developments
7.7 Soricimed Biopharma
7.7.1 Soricimed Biopharma Company Summary
7.7.2 Soricimed Biopharma Business Overview
7.7.3 Soricimed Biopharma Peptide-Drug Conjugates Major Product Offerings
7.7.4 Soricimed Biopharma Peptide-Drug Conjugates Revenue in Global Market (2018-2023)
7.7.5 Soricimed Biopharma Key News & Latest Developments
7.8 Theratechnologies
7.8.1 Theratechnologies Company Summary
7.8.2 Theratechnologies Business Overview
7.8.3 Theratechnologies Peptide-Drug Conjugates Major Product Offerings
7.8.4 Theratechnologies Peptide-Drug Conjugates Revenue in Global Market (2018-2023)
7.8.5 Theratechnologies Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Peptide-Drug Conjugates Market Opportunities & Trends in Global Market
Table 2. Peptide-Drug Conjugates Market Drivers in Global Market
Table 3. Peptide-Drug Conjugates Market Restraints in Global Market
Table 4. Key Players of Peptide-Drug Conjugates in Global Market
Table 5. Top Peptide-Drug Conjugates Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Peptide-Drug Conjugates Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Peptide-Drug Conjugates Revenue Share by Companies, 2018-2023
Table 8. Global Companies Peptide-Drug Conjugates Product Type
Table 9. List of Global Tier 1 Peptide-Drug Conjugates Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Peptide-Drug Conjugates Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Peptide-Drug Conjugates Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Peptide-Drug Conjugates Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Peptide-Drug Conjugates Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global Peptide-Drug Conjugates Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Peptide-Drug Conjugates Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Peptide-Drug Conjugates Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global Peptide-Drug Conjugates Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Peptide-Drug Conjugates Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Peptide-Drug Conjugates Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America Peptide-Drug Conjugates Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Peptide-Drug Conjugates Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe Peptide-Drug Conjugates Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Peptide-Drug Conjugates Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia Peptide-Drug Conjugates Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Peptide-Drug Conjugates Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America Peptide-Drug Conjugates Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Peptide-Drug Conjugates Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa Peptide-Drug Conjugates Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Peptide-Drug Conjugates Revenue, (US$, Mn), 2024-2032
Table 30. AstraZeneca Company Summary
Table 31. AstraZeneca Peptide-Drug Conjugates Product Offerings
Table 32. AstraZeneca Peptide-Drug Conjugates Revenue (US$, Mn) & (2018-2023)
Table 33. AstraZeneca Key News & Latest Developments
Table 34. Bicycle Therapeutics Company Summary
Table 35. Bicycle Therapeutics Peptide-Drug Conjugates Product Offerings
Table 36. Bicycle Therapeutics Peptide-Drug Conjugates Revenue (US$, Mn) & (2018-2023)
Table 37. Bicycle Therapeutics Key News & Latest Developments
Table 38. Cybrexa Therapeutics Company Summary
Table 39. Cybrexa Therapeutics Peptide-Drug Conjugates Product Offerings
Table 40. Cybrexa Therapeutics Peptide-Drug Conjugates Revenue (US$, Mn) & (2018-2023)
Table 41. Cybrexa Therapeutics Key News & Latest Developments
Table 42. Esperance Pharmaceuticals Company Summary
Table 43. Esperance Pharmaceuticals Peptide-Drug Conjugates Product Offerings
Table 44. Esperance Pharmaceuticals Peptide-Drug Conjugates Revenue (US$, Mn) & (2018-2023)
Table 45. Esperance Pharmaceuticals Key News & Latest Developments
Table 46. Oncopeptides Company Summary
Table 47. Oncopeptides Peptide-Drug Conjugates Product Offerings
Table 48. Oncopeptides Peptide-Drug Conjugates Revenue (US$, Mn) & (2018-2023)
Table 49. Oncopeptides Key News & Latest Developments
Table 50. Pepgen Corporation Company Summary
Table 51. Pepgen Corporation Peptide-Drug Conjugates Product Offerings
Table 52. Pepgen Corporation Peptide-Drug Conjugates Revenue (US$, Mn) & (2018-2023)
Table 53. Pepgen Corporation Key News & Latest Developments
Table 54. Soricimed Biopharma Company Summary
Table 55. Soricimed Biopharma Peptide-Drug Conjugates Product Offerings
Table 56. Soricimed Biopharma Peptide-Drug Conjugates Revenue (US$, Mn) & (2018-2023)
Table 57. Soricimed Biopharma Key News & Latest Developments
Table 58. Theratechnologies Company Summary
Table 59. Theratechnologies Peptide-Drug Conjugates Product Offerings
Table 60. Theratechnologies Peptide-Drug Conjugates Revenue (US$, Mn) & (2018-2023)
Table 61. Theratechnologies Key News & Latest Developments
List of Figures
Figure 1. Peptide-Drug Conjugates Segment by Type in 2022
Figure 2. Peptide-Drug Conjugates Segment by Application in 2022
Figure 3. Global Peptide-Drug Conjugates Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Peptide-Drug Conjugates Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Peptide-Drug Conjugates Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Peptide-Drug Conjugates Revenue in 2022
Figure 8. By Type - Global Peptide-Drug Conjugates Revenue Market Share, 2018-2032
Figure 9. By Application - Global Peptide-Drug Conjugates Revenue Market Share, 2018-2032
Figure 10. By Type - Global Peptide-Drug Conjugates Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global Peptide-Drug Conjugates Revenue Market Share, 2018-2032
Figure 12. By Application - Global Peptide-Drug Conjugates Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global Peptide-Drug Conjugates Revenue Market Share, 2018-2032
Figure 14. By Region - Global Peptide-Drug Conjugates Revenue Market Share, 2018-2032
Figure 15. By Country - North America Peptide-Drug Conjugates Revenue Market Share, 2018-2032
Figure 16. US Peptide-Drug Conjugates Revenue, (US$, Mn), 2018-2032
Figure 17. Canada Peptide-Drug Conjugates Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico Peptide-Drug Conjugates Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe Peptide-Drug Conjugates Revenue Market Share, 2018-2032
Figure 20. Germany Peptide-Drug Conjugates Revenue, (US$, Mn), 2018-2032
Figure 21. France Peptide-Drug Conjugates Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. Peptide-Drug Conjugates Revenue, (US$, Mn), 2018-2032
Figure 23. Italy Peptide-Drug Conjugates Revenue, (US$, Mn), 2018-2032
Figure 24. Russia Peptide-Drug Conjugates Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries Peptide-Drug Conjugates Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux Peptide-Drug Conjugates Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia Peptide-Drug Conjugates Revenue Market Share, 2018-2032
Figure 28. China Peptide-Drug Conjugates Revenue, (US$, Mn), 2018-2032
Figure 29. Japan Peptide-Drug Conjugates Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea Peptide-Drug Conjugates Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia Peptide-Drug Conjugates Revenue, (US$, Mn), 2018-2032
Figure 32. India Peptide-Drug Conjugates Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America Peptide-Drug Conjugates Revenue Market Share, 2018-2032
Figure 34. Brazil Peptide-Drug Conjugates Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina Peptide-Drug Conjugates Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa Peptide-Drug Conjugates Revenue Market Share, 2018-2032
Figure 37. Turkey Peptide-Drug Conjugates Revenue, (US$, Mn), 2018-2032
Figure 38. Israel Peptide-Drug Conjugates Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia Peptide-Drug Conjugates Revenue, (US$, Mn), 2018-2032
Figure 40. UAE Peptide-Drug Conjugates Revenue, (US$, Mn), 2018-2032
Figure 41. AstraZeneca Peptide-Drug Conjugates Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Bicycle Therapeutics Peptide-Drug Conjugates Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Cybrexa Therapeutics Peptide-Drug Conjugates Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Esperance Pharmaceuticals Peptide-Drug Conjugates Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Oncopeptides Peptide-Drug Conjugates Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Pepgen Corporation Peptide-Drug Conjugates Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Soricimed Biopharma Peptide-Drug Conjugates Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Theratechnologies Peptide-Drug Conjugates Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
